Testsigma, a San Francisco, California-based AI-powered, low-code test automation platform, raised $8.2 million in the funding round.
In conjunction with the funding announcement, the company unveiled new GenAI capabilities to enhance its low-code platform.
Investors
The round was led by MassMutual Ventures, with participation from existing investors Accel, Strive, and BoldCap.
Founded in 2014, MMV is a multistage, global venture capital firm investing in enterprise software, cybersecurity, financial technology, and digital health companies.
About Testigma
Founded in 2019 by Rukmangada Kandyala, Pratheep Velicherla, Vikram Chaitanya, and Rajesh Reddy, Testsigma provides a GenAI-powered, low-code test automation platform for quality engineering teams to automate tests at speed and scale without coding expertise. The company leverages its Natural Language Programming (NLP) engine to allow users to create, manage, and execute comprehensive automated tests for web and mobile applications, as well as Application Programming Interfaces (APIs). Some notable customers of Testsigma include Cisco, Samsung, Bosch, Oscar Health, and American Psychological Association. Testsigma is headquartered in San Francisco with engineering teams in Bangalore and Chennai.
Funding Details
Company: Testsigma Technologies Inc.
Raised: $8.2M
Round: Unknown
Funding Month: June 2024
Lead Investors: MassMutual Ventures
Additional Investors: Accel, Strive, BoldCap
Company Website: https://testsigma.com/
Software Category: Automated Testing
Source: https://www.prnewswire.com/news-releases/testsigma-raises-8-2m-led-by-massmutual-ventures-302164539.html